NHS Surrey Commissions Risk Stratification Tool from Docobo Ltd to Reduce Unplanned Admissions

Innovative technology developed by UK company Docobo Ltd, will support NHS Surrey in their initiatives to manage patients at home and reduce hospital admissions. NHS Surrey has commissioned Docobo Ltd to supply its new risk stratification tool, ArtemusICS™, that will enable GP practices in Surrey to better target their resources to deliver better outcomes for the 1.2 million people living in Surrey.

The tool takes patient data from both Primary and Secondary care and, through detailed analysis, will identify patients at risk of requiring future healthcare resources and who would likely benefit from a specific Long Term Condition intervention. The data is presented in a convenient 'dashboard' format so that information can be easily accessed via secure web access by authorised staff at GP practices. Data can be examined based on groups of patients, such as by practice or locality, or by clinical condition. Each patient is allocated a 'risk score' which predicts their risk of a hospital admission in the next year. Their GP can view this data and use it to direct their resources more effectively. This enables them toprovide more targeted personalised care and will help to identify and treat health problems earlier. Furthermore, the patients' risk scores can be monitored regularly to examine the effect effectiveness of treatments and interventions.

"We chose the ArtemusICS tool because it enables clinicians to target patients who would benefit from greater intervention, helping to reduce unplanned hospital admissions, which can be very distressing. Using this tool helps clinicians achieve the best possible outcomes for their patients and it also enables them to allocate their resources to best effect," said Christine Ratcliffe, Associate Director of IT Programmes, NHS Surrey. "The tool creates dashboards, which are easy to access, and give clinicians valuable insight into primary and seconday care data, helping them identify those most at risk and enabling them to tailor care to meet their needs. Docobo have worked with us to develop the tool to meet our requirements, and have delivered a quality product that is already making a real difference to GPs."

"Docobo is proud that our ArtemusICS system has been selected by NHS Surrey," said Adrian Flowerday, Managing Director, Docobo Ltd. "We are particularly delighted to have had the opportunity to work closely with Surrey to develop this tool to precisely fit their needs and we look forward to working with the GP practices in Surrey to roll this out."

About Docobo Ltd
Docobo Ltd is a UK medical device company that supplies eHealth solutions to enable Community Care and improve the quality of life of patients, carers and clinicians. More than 40 PCTs and Trusts in the UK and several international healthcare organisations are currently using doc@HOME Telehealth to support their patients.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...